173 related articles for article (PubMed ID: 38798766)
1. A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit.
Al-Hersh E; Abushanab D; AbouNahia F; Rainkie D; Al Hail M; Abdulrouf PV; El-Kassem W; Al-Badriyeh D
J Pharm Policy Pract; 2024; 17(1):2345218. PubMed ID: 38798766
[TBL] [Abstract][Full Text] [Related]
2. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study.
Abushanab D; Rouf PA; Al Hail M; Kamal R; Viswanathan B; Parappil H; Elkassem W; Al-Shaibi S; Al-Badriyeh D
Clin Ther; 2021 Feb; 43(2):336-348.e7. PubMed ID: 33431169
[TBL] [Abstract][Full Text] [Related]
4. Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study.
Rauf S; Shah S; Bibi Z; Munir R; Jiskani H; Ahmad S; Mir Shah SA; Bibi A; Fasih Ahmad H; Hussain K; Ariff S; Ambreen G
Inquiry; 2024; 61():469580241248098. PubMed ID: 38666733
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Economic Analysis of Morphine Versus Fentanyl in Managing Ventilated Neonates With Respiratory Distress Syndrome in the Intensive Care Setting.
Abushanab D; Alsoukhni O; AbouNahia F; Al-Badriyeh D
Clin Ther; 2019 Apr; 41(4):714-727.e8. PubMed ID: 30846286
[TBL] [Abstract][Full Text] [Related]
6. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
[TBL] [Abstract][Full Text] [Related]
7. Relationship of caffeine regimen with osteopenia of prematurity in preterm neonates: a cohort retrospective study.
Kumar M; Ali A; Khan MA; Sohail S; Saleem SM; Khan M; Naz F; Khan WA; Salat MS; Hussain K; Ambreen G
BMC Pediatr; 2022 Jul; 22(1):437. PubMed ID: 35864501
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Discharging Preterm Infants Home on Caffeine, a Single Center Experience.
Ma C; Broadbent D; Levin G; Panda S; Sambalingam D; Garcia N; Ruiz E; Singh AP
Children (Basel); 2020 Aug; 7(9):. PubMed ID: 32872145
[No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.
Chen J; Jin L; Chen X
Biomed Res Int; 2018; 2018():9061234. PubMed ID: 30671477
[TBL] [Abstract][Full Text] [Related]
11. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses.
Alhersh E; Abushanab D; Al-Shaibi S; Al-Badriyeh D
Paediatr Drugs; 2020 Aug; 22(4):399-408. PubMed ID: 32488731
[TBL] [Abstract][Full Text] [Related]
12. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
Dobson NR; Hunt CE
Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
[TBL] [Abstract][Full Text] [Related]
13. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
[TBL] [Abstract][Full Text] [Related]
14. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
[TBL] [Abstract][Full Text] [Related]
15. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study.
Ambreen G; Kumar M; Ali A; Shah SAA; Saleem SM; Tahir A; Salat MS; Aslam MS; Hussain K
PLoS One; 2022; 17(11):e0275655. PubMed ID: 36350877
[TBL] [Abstract][Full Text] [Related]
17. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
Moresco L; Sjögren A; Marques KA; Soll R; Bruschettini M
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015462. PubMed ID: 37791592
[TBL] [Abstract][Full Text] [Related]
18. Caffeine Therapy for Apnea of Prematurity: Role of the Circadian
Guo HL; Long JY; Hu YH; Liu Y; He X; Li L; Xia Y; Ding XS; Chen F; Xu J; Cheng R
Front Pharmacol; 2021; 12():724145. PubMed ID: 35145399
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
[TBL] [Abstract][Full Text] [Related]
20. Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.
Wan L; Huang L; Chen P
Pediatr Pulmonol; 2020 Oct; 55(10):2635-2640. PubMed ID: 32639634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
